-
1
-
-
84859153479
-
Raising the bar: the curative potential of human cancer immunotherapy
-
127ps8.
-
Rosenberg SA. Raising the bar: the curative potential of human cancer immunotherapy. Sci Transl Med. 2012;4:127ps8.
-
(2012)
Sci Transl Med
, vol.4
-
-
Rosenberg, S.A.1
-
3
-
-
65249101637
-
The promise and potential pitfalls of chimeric antigen receptors
-
Sadelain M, Brentjens R, Riviere I. The promise and potential pitfalls of chimeric antigen receptors. Curr Opin Immunol. 2009;21:215-23.
-
(2009)
Curr Opin Immunol
, vol.21
, pp. 215-223
-
-
Sadelain, M.1
Brentjens, R.2
Riviere, I.3
-
4
-
-
80051775476
-
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia
-
95ra73.
-
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med. 2011;3:95ra73.
-
(2011)
Sci Transl Med
, vol.3
-
-
Kalos, M.1
Levine, B.L.2
Porter, D.L.3
Katz, S.4
Grupp, S.A.5
Bagg, A.6
-
5
-
-
84896335556
-
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
-
Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014;6:224ra25.
-
(2014)
Sci Transl Med
, vol.6
, pp. 224-225
-
-
Davila, M.L.1
Riviere, I.2
Wang, X.3
Bartido, S.4
Park, J.5
Curran, K.6
-
6
-
-
84863337890
-
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
-
Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood. 2012;119:2709-20.
-
(2012)
Blood
, vol.119
, pp. 2709-2720
-
-
Kochenderfer, J.N.1
Dudley, M.E.2
Feldman, S.A.3
Wilson, W.H.4
Spaner, D.E.5
Maric, I.6
-
7
-
-
84923019006
-
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
-
Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015;385:517-28.
-
(2015)
Lancet
, vol.385
, pp. 517-528
-
-
Lee, D.W.1
Kochenderfer, J.N.2
Stetler-Stevenson, M.3
Cui, Y.K.4
Delbrook, C.5
Feldman, S.A.6
-
8
-
-
84887821770
-
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
-
Cruz CRY, Micklethwaite KP, Savoldo B, Ramos CA, Lam S, Ku S, et al. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood. 2013;122:2965-73.
-
(2013)
Blood
, vol.122
, pp. 2965-2973
-
-
Cruz, C.R.Y.1
Micklethwaite, K.P.2
Savoldo, B.3
Ramos, C.A.4
Lam, S.5
Ku, S.6
-
9
-
-
80455179612
-
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
-
Brentjens RJ, Rivière I, Park JH, Davila ML, Wang X, Stefanski J, et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood. 2011;118:4817-28.
-
(2011)
Blood
, vol.118
, pp. 4817-4828
-
-
Brentjens, R.J.1
Rivière, I.2
Park, J.H.3
Davila, M.L.4
Wang, X.5
Stefanski, J.6
-
10
-
-
84876005284
-
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
-
177ra38.
-
Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med. 2013;5:177ra38.
-
(2013)
Sci Transl Med
, vol.5
-
-
Brentjens, R.J.1
Davila, M.L.2
Riviere, I.3
Park, J.4
Wang, X.5
Cowell, L.G.6
-
11
-
-
84923118622
-
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an Anti-CD19 Chimeric antigen receptor
-
Kochenderfer JN, Dudley ME, Kassim SH, Somerville RPT, Carpenter RO, Stetler-Stevenson M, et al. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an Anti-CD19 Chimeric antigen receptor. J Clin Oncol. 2015;33:540-9.
-
(2015)
J Clin Oncol
, vol.33
, pp. 540-549
-
-
Kochenderfer, J.N.1
Dudley, M.E.2
Kassim, S.H.3
Somerville, R.P.T.4
Carpenter, R.O.5
Stetler-Stevenson, M.6
-
12
-
-
84902590274
-
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
-
Xu Y, Zhang M, Ramos CA, Durett A, Liu E, Dakhova O, et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood. 2014;123:3750-9.
-
(2014)
Blood
, vol.123
, pp. 3750-3759
-
-
Xu, Y.1
Zhang, M.2
Ramos, C.A.3
Durett, A.4
Liu, E.5
Dakhova, O.6
-
13
-
-
84918779798
-
TCR-engineered T cells to treat solid tumors: T cell processing towards optimal T cell fitness
-
Lamers CHJ, van Steenbergen-Langeveld S, van Brakel M, Groot-van Ruijven CM, van Elzakker PMML, van Krimpen B, et al. TCR-engineered T cells to treat solid tumors: T cell processing towards optimal T cell fitness. Hum Gene Ther Methods. 2014;25:345-57.
-
(2014)
Hum Gene Ther Methods
, vol.25
, pp. 345-357
-
-
Lamers, C.H.J.1
van Steenbergen-Langeveld, S.2
van Brakel, M.3
Groot-van Ruijven, C.M.4
van Elzakker, P.M.M.L.5
van Krimpen, B.6
-
14
-
-
84905996839
-
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
-
Guedan S, Chen X, Madar A, Carpenito C, McGettigan SE, Frigault MJ, et al. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells. Blood. 2014;124:1070-80.
-
(2014)
Blood
, vol.124
, pp. 1070-1080
-
-
Guedan, S.1
Chen, X.2
Madar, A.3
Carpenito, C.4
McGettigan, S.E.5
Frigault, M.J.6
-
15
-
-
38149117105
-
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
-
Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest. 2008;118:294-305.
-
(2008)
J Clin Invest
, vol.118
, pp. 294-305
-
-
Berger, C.1
Jensen, M.C.2
Lansdorp, P.M.3
Gough, M.4
Elliott, C.5
Riddell, S.R.6
-
16
-
-
70350458112
-
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
-
Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, Yu Z, et al. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci U S A. 2009;106:17469-74.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 17469-17474
-
-
Hinrichs, C.S.1
Borman, Z.A.2
Cassard, L.3
Gattinoni, L.4
Spolski, R.5
Yu, Z.6
-
17
-
-
77952679687
-
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
-
Chen YY, Jensen MC, Smolke CD. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc Natl Acad Sci U S A. 2010;107:8531-6.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 8531-8536
-
-
Chen, Y.Y.1
Jensen, M.C.2
Smolke, C.D.3
-
18
-
-
84862954607
-
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
-
Terakura S, Yamamoto TN, Gardner RA, Turtle CJ, Jensen MC, Riddell SR. Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells. Blood. 2012;119:72-82.
-
(2012)
Blood
, vol.119
, pp. 72-82
-
-
Terakura, S.1
Yamamoto, T.N.2
Gardner, R.A.3
Turtle, C.J.4
Jensen, M.C.5
Riddell, S.R.6
-
19
-
-
33845294816
-
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
-
Kowolik CM, Topp MS, Gonzalez S, Pfeiffer T, Olivares S, Gonzalez N, et al. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. Cancer Res. 2006;66:10995-1004.
-
(2006)
Cancer Res
, vol.66
, pp. 10995-11004
-
-
Kowolik, C.M.1
Topp, M.S.2
Gonzalez, S.3
Pfeiffer, T.4
Olivares, S.5
Gonzalez, N.6
-
20
-
-
80051589534
-
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
-
Wang X, Chang WC, Wong CW, Colcher D, Sherman M, Ostberg JR, et al. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells. Blood. 2011;118:1255-63.
-
(2011)
Blood
, vol.118
, pp. 1255-1263
-
-
Wang, X.1
Chang, W.C.2
Wong, C.W.3
Colcher, D.4
Sherman, M.5
Ostberg, J.R.6
-
21
-
-
28444455974
-
Secretion of IFN-gamma and not IL-2 by anergic human T cells correlates with assembly of an immature immune synapse
-
Carlin LM, Yanagi K, Verhoef A, Nolte-'t Hoen ENM, Yates J, Gardner L, et al. Secretion of IFN-gamma and not IL-2 by anergic human T cells correlates with assembly of an immature immune synapse. Blood. 2005;106:3874-9.
-
(2005)
Blood
, vol.106
, pp. 3874-3879
-
-
Carlin, L.M.1
Yanagi, K.2
Verhoef, A.3
Nolte-'t Hoen, E.N.M.4
Yates, J.5
Gardner, L.6
-
22
-
-
0033655529
-
Human T lymphocyte genetic modification with naked DNA
-
Jensen MC, Clarke P, Tan G, Wright C, Chung-Chang W, Clark TN, et al. Human T lymphocyte genetic modification with naked DNA. Mol Ther. 2000;1:49-55.
-
(2000)
Mol Ther
, vol.1
, pp. 49-55
-
-
Jensen, M.C.1
Clarke, P.2
Tan, G.3
Wright, C.4
Chung-Chang, W.5
Clark, T.N.6
-
23
-
-
34548485103
-
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains
-
Wang J, Jensen M, Lin Y, Sui X, Chen E, Lindgren CG, et al. Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains. Hum Gene Ther. 2007;18:712-25.
-
(2007)
Hum Gene Ther
, vol.18
, pp. 712-725
-
-
Wang, J.1
Jensen, M.2
Lin, Y.3
Sui, X.4
Chen, E.5
Lindgren, C.G.6
-
24
-
-
33847401888
-
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
-
Blank C, Mackensen A. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol Immunother. 2007;56:739-45.
-
(2007)
Cancer Immunol Immunother
, vol.56
, pp. 739-745
-
-
Blank, C.1
Mackensen, A.2
-
25
-
-
70349569569
-
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
-
Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE, et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood. 2009;114:1537-44.
-
(2009)
Blood
, vol.114
, pp. 1537-1544
-
-
Ahmadzadeh, M.1
Johnson, L.A.2
Heemskerk, B.3
Wunderlich, J.R.4
Dudley, M.E.5
White, D.E.6
-
26
-
-
77957059176
-
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
-
Jin HT, Anderson AC, Tan WG, West EE, Ha SJ, Araki K, et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 2010;107:14733-8.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 14733-14738
-
-
Jin, H.T.1
Anderson, A.C.2
Tan, W.G.3
West, E.E.4
Ha, S.J.5
Araki, K.6
-
27
-
-
79956048616
-
Progressive upregulation of PD-1 in primary and metastatic melanomas associated with blunted TCR signaling in infiltrating T lymphocytes
-
Chapon M, Randriamampita C, Maubec E, Badoual C, Fouquet S, Wang S-F, et al. Progressive upregulation of PD-1 in primary and metastatic melanomas associated with blunted TCR signaling in infiltrating T lymphocytes. J Invest Dermatol. 2011;131:1300-7.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 1300-1307
-
-
Chapon, M.1
Randriamampita, C.2
Maubec, E.3
Badoual, C.4
Fouquet, S.5
Wang, S.-F.6
-
28
-
-
84878458037
-
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
-
Brusa D, Serra S, Coscia M, Rossi D, D'Arena G, Laurenti L, et al. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica. 2013;98:953-63.
-
(2013)
Haematologica
, vol.98
, pp. 953-963
-
-
Brusa, D.1
Serra, S.2
Coscia, M.3
Rossi, D.4
D'Arena, G.5
Laurenti, L.6
-
29
-
-
82955187824
-
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor
-
Nakazawa Y, Huye LE, Salsman VS, Leen AM, Ahmed N, Rollins L, et al. PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther. 2011;19:2133-43.
-
(2011)
Mol Ther
, vol.19
, pp. 2133-2143
-
-
Nakazawa, Y.1
Huye, L.E.2
Salsman, V.S.3
Leen, A.M.4
Ahmed, N.5
Rollins, L.6
-
30
-
-
84856071702
-
CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
-
Song D-G, Ye Q, Poussin M, Harms GM, Figini M, Powell DJ. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood. 2012;119:696-706.
-
(2012)
Blood
, vol.119
, pp. 696-706
-
-
Song, D.-G.1
Ye, Q.2
Poussin, M.3
Harms, G.M.4
Figini, M.5
Powell, D.J.6
-
31
-
-
33947265424
-
Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma
-
Park JR, Digiusto DL, Slovak M, Wright C, Naranjo A, Wagner J, et al. Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma. Mol Ther. 2007;15:825-33.
-
(2007)
Mol Ther
, vol.15
, pp. 825-833
-
-
Park, J.R.1
Digiusto, D.L.2
Slovak, M.3
Wright, C.4
Naranjo, A.5
Wagner, J.6
-
32
-
-
3142707099
-
Enhanced transgene expression in quiescent and activated human CD8+ T cells
-
Cooper LJN, Topp MS, Pinzon C, Plavec I, Jensen MC, Riddell SR, et al. Enhanced transgene expression in quiescent and activated human CD8+ T cells. Hum Gene Ther. 2004;15:648-58.
-
(2004)
Hum Gene Ther
, vol.15
, pp. 648-658
-
-
Cooper, L.J.N.1
Topp, M.S.2
Pinzon, C.3
Plavec, I.4
Jensen, M.C.5
Riddell, S.R.6
-
33
-
-
70449486486
-
Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
-
Burns WR, Zheng Z, Rosenberg SA, Morgan RA. Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation. Blood. 2009;114:2888-99.
-
(2009)
Blood
, vol.114
, pp. 2888-2899
-
-
Burns, W.R.1
Zheng, Z.2
Rosenberg, S.A.3
Morgan, R.A.4
-
34
-
-
80051720194
-
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
-
Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365:725-33.
-
(2011)
N Engl J Med
, vol.365
, pp. 725-733
-
-
Porter, D.L.1
Levine, B.L.2
Kalos, M.3
Bagg, A.4
June, C.H.5
-
35
-
-
84908073316
-
Chimeric antigen receptor T cells for sustained remissions in leukemia
-
Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507-17.
-
(2014)
N Engl J Med
, vol.371
, pp. 1507-1517
-
-
Maude, S.L.1
Frey, N.2
Shaw, P.A.3
Aplenc, R.4
Barrett, D.M.5
Bunin, N.J.6
-
36
-
-
70349232884
-
Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells
-
Sacristán C, Schattgen SA, Berg LJ, Bunnell SC, Roy AL, Rosenstein Y. Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells. Eur J Immunol. 2009;39:2584-95.
-
(2009)
Eur J Immunol
, vol.39
, pp. 2584-2595
-
-
Sacristán, C.1
Schattgen, S.A.2
Berg, L.J.3
Bunnell, S.C.4
Roy, A.L.5
Rosenstein, Y.6
-
37
-
-
79960414060
-
Sterol regulatory element-binding protein 2 couples HIV-1 transcription to cholesterol homeostasis and T cell activation
-
Taylor HE, Linde ME, Khatua AK, Popik W, Hildreth JEK. Sterol regulatory element-binding protein 2 couples HIV-1 transcription to cholesterol homeostasis and T cell activation. J Virol. 2011;85:7699-709.
-
(2011)
J Virol
, vol.85
, pp. 7699-7709
-
-
Taylor, H.E.1
Linde, M.E.2
Khatua, A.K.3
Popik, W.4
Hildreth, J.E.K.5
-
38
-
-
50549096284
-
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
-
Till BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, et al. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood. 2008;112:2261-71.
-
(2008)
Blood
, vol.112
, pp. 2261-2271
-
-
Till, B.G.1
Jensen, M.C.2
Wang, J.3
Chen, E.Y.4
Wood, B.L.5
Greisman, H.A.6
-
39
-
-
32644451168
-
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity
-
Hirano N, Butler MO, Xia Z, Ansén S, von Bergwelt-Baildon MS, Neuberg D, et al. Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood. 2006;107:1528-36.
-
(2006)
Blood
, vol.107
, pp. 1528-1536
-
-
Hirano, N.1
Butler, M.O.2
Xia, Z.3
Ansén, S.4
von Bergwelt-Baildon, M.S.5
Neuberg, D.6
-
40
-
-
0036171757
-
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB
-
Maus MV, Thomas AK, Leonard DGB, Allman D, Addya K, Schlienger K, et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat Biotechnol. 2002;20:143-8.
-
(2002)
Nat Biotechnol
, vol.20
, pp. 143-148
-
-
Maus, M.V.1
Thomas, A.K.2
Leonard, D.G.B.3
Allman, D.4
Addya, K.5
Schlienger, K.6
-
41
-
-
34247212403
-
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
-
Suhoski MM, Golovina TN, Aqui NA, Tai VC, Varela-Rohena A, Milone MC, et al. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther. 2007;15:981-8.
-
(2007)
Mol Ther
, vol.15
, pp. 981-988
-
-
Suhoski, M.M.1
Golovina, T.N.2
Aqui, N.A.3
Tai, V.C.4
Varela-Rohena, A.5
Milone, M.C.6
-
42
-
-
18544380239
-
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
-
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793-800.
-
(2002)
Nat Med
, vol.8
, pp. 793-800
-
-
Dong, H.1
Strome, S.E.2
Salomao, D.R.3
Tamura, H.4
Hirano, F.5
Flies, D.B.6
-
43
-
-
0037126021
-
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
-
Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 2002;99:12293-7.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 12293-12297
-
-
Iwai, Y.1
Ishida, M.2
Tanaka, Y.3
Okazaki, T.4
Honjo, T.5
Minato, N.6
-
44
-
-
13444270323
-
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity
-
Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M, et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 2005;65:1089-96.
-
(2005)
Cancer Res
, vol.65
, pp. 1089-1096
-
-
Hirano, F.1
Kaneko, K.2
Tamura, H.3
Dong, H.4
Wang, S.5
Ichikawa, M.6
-
45
-
-
0034596948
-
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
-
Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192:1027-34.
-
(2000)
J Exp Med
, vol.192
, pp. 1027-1034
-
-
Freeman, G.J.1
Long, A.J.2
Iwai, Y.3
Bourque, K.4
Chernova, T.5
Nishimura, H.6
-
46
-
-
84905993539
-
Multifactorial T cell hypofunction that is reversible can limit the efficacy of chimeric antibody receptor-transduced human T cells in solid tumors
-
Moon EK, Wang L-CS, Dolfi DV, Wilson CB, Ranganathan R, Sun J, et al. Multifactorial T cell hypofunction that is reversible can limit the efficacy of chimeric antibody receptor-transduced human T cells in solid tumors. Clin Cancer Res. 2014;20:4262-73.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 4262-4273
-
-
Moon, E.K.1
Wang, L.-C.2
Dolfi, D.V.3
Wilson, C.B.4
Ranganathan, R.5
Sun, J.6
-
47
-
-
84886397930
-
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells
-
John LB, Devaud C, Duong CPM, Yong CS, Beavis PA, Haynes NM, et al. Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells. Clin Cancer Res. 2013;19:5636-46.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 5636-5646
-
-
John, L.B.1
Devaud, C.2
Duong, C.P.M.3
Yong, C.S.4
Beavis, P.A.5
Haynes, N.M.6
|